Article Information
History
- February 16, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Divora Yemane1,*,
- Ivan Lu1,*,
- Winson Tiahjono1,
- Lauren Rubidoux1,
- Abbas Hussain1,
- John C. Cancilla2,
- Erika Duggan2,
- Nathan C. Shaner1,
- Nobuki Nakanishi1,2 and
- Jiwu Wang1,2,#
- 1Allele Biotechnology and Pharmaceuticals, Inc., 6404 Nancy Ridge Drive, San Diego, CA 92121
- 2Scintillon Institute, 6868 Nancy Ridge Drive, San Diego, CA 92121
- ↵#Corresponding Author:
Jiwu Wang, Ph.D. jiwuwang{at}allelebiotech.com
↵* These authors contributed equally.
Posted February 16, 2021.
Single-Domain SARS-CoV-2 S1 and RBD Antibodies Isolated from Immunized Llama Effectively Bind Targets of the Wuhan, UK, and South African Strains in vitro
